Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Valeant Completes $2 Billion Credit Facility

Date: 10/20/11

Cahill represented the arrangers and administrative agent in connection with a $2.0 billion credit facility comprised of a $1,225,000,000 Term A loan, a $275,000,000 revolving credit facility, and a $500,000,000 delayed draw term loan for Valeant Pharmaceuticals International, Inc. The proceeds will be used to refinance existing indebtedness, finance acquisitions, and for general corporate purposes.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com